Genetic Alliance Expands Global Genomics Laboratory Network with Three New Partners
Genetic Alliance today announced that three leading laboratories - Children’s Mercy (Kansas City, Missouri, USA), SN Genelab (Surat, India), and Xcelom (Hong Kong) - have joined its global genomics network, RISE- Rare Insights, Solutions, Empowerment, broadening the organization’s capacity to connect children and families affected by genetic conditions with advanced testing and extending its reach into new regions.
Together, the three laboratories will provide clinical whole genome sequencing using Pacific Biosciences (PacBio) HiFi long-read technology at no cost to eligible families referred through Genetic Alliance’s global network of 26 clinical sites in 14 countries. The laboratories were selected through a competitive application process based on demonstrated excellence in clinical genomic testing, robust quality systems, and a shared commitment to expanding equitable access to genomic medicine. Each met Genetic Alliance’s rigorous standards for clinical quality, technical capability, and collaborative engagement.
To date, the program has provided no-cost genomic testing to nearly 4,000 underserved families. The addition of these laboratories expands Genetic Alliance’s global testing capacity, enabling more children with suspected rare genetic diseases to receive genomic testing regardless of where they live.
· Children’s Mercy (Kansas City, Missouri, USA) is an internationally recognized leader in pediatric genomic medicine and rare disease diagnosis, bringing deep clinical expertise and advanced genomic capabilities to the network. Children's Mercy's initial work through the network will support testing for patients referred by Dr. Mario Cornejo Olivas at Instituto Nacional de Ciencias Neurológicas in Lima, Peru.
· SN Genelab (Surat, India) is Genetic Alliance’s first laboratory partner in India, expanding access to high-quality genomic testing in South Asia and strengthening regional capacity.
· Xcelom (Hong Kong SAR, China), a subsidiary of Berry Genomics, is Genetic Alliance’s first laboratory partner in Hong Kong. Xcelom provides clinically validated long-read whole genome sequencing and will help extend access to advanced genomic testing across the Asia-Pacific region.
“Every laboratory we add to the network brings new expertise, technologies and opportunities for children who might otherwise never receive a genetic diagnosis,” said Ryan Taft, Chief Scientific Officer, Genetic Alliance. “Growing this patient-first international consortium allows us to reach families wherever they live.”
Through its global genomics initiatives, Genetic Alliance partners with clinical sites, laboratories, researchers, and community organizations to expand equitable access to genomic testing and accelerate the integration of genomic medicine into patient care worldwide. The addition of these three laboratories further strengthens a growing global network dedicated to delivering high-quality genomic testing to underserved families.